Learning the value of drugs--is rofecoxib a regulatory success story?
- PMID: 15800222
- DOI: 10.1056/NEJMp048358
Learning the value of drugs--is rofecoxib a regulatory success story?
Similar articles
-
Raising the safety bar--the FDA's coxib meeting.N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055. N Engl J Med. 2005. PMID: 15800221 No abstract available.
-
What ails the FDA?N Engl J Med. 2005 Mar 17;352(11):1063-6. doi: 10.1056/NEJMp058003. N Engl J Med. 2005. PMID: 15784660 No abstract available.
-
Rofecoxib, Merck, and the FDA.N Engl J Med. 2004 Dec 30;351(27):2875-8; author reply 2875-8. N Engl J Med. 2004. PMID: 15625745 No abstract available.
-
COX-2 inhibitors and the heart: putting risk in perspective.Adv Nurse Pract. 2005 Nov;13(11):48-50. Adv Nurse Pract. 2005. PMID: 16295003 Review. No abstract available.
-
Methodology of therapeutic trials: lessons from the late evidence of the cardiovascular toxicity of some coxibs.Joint Bone Spine. 2005 Dec;72(6):451-5. doi: 10.1016/j.jbspin.2005.10.003. Epub 2005 Oct 25. Joint Bone Spine. 2005. PMID: 16330235 Review.
Cited by
-
Evaluation of drug toxicity in clinical trials.Sci Eng Ethics. 2006 Jan;12(1):139-45. doi: 10.1007/s11948-006-0014-y. Sci Eng Ethics. 2006. PMID: 16501655
-
Getting it right: being smarter about clinical trials.PLoS Med. 2006 Apr;3(6):e144. doi: 10.1371/journal.pmed.0030144. PLoS Med. 2006. PMID: 16608383 Free PMC article.
-
Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004.BMC Health Serv Res. 2010 Jul 25;10:218. doi: 10.1186/1472-6963-10-218. BMC Health Serv Res. 2010. PMID: 20653979 Free PMC article.
-
Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?Proc (Bayl Univ Med Cent). 2008 Jan;21(1):82-92. doi: 10.1080/08998280.2008.11928368. Proc (Bayl Univ Med Cent). 2008. PMID: 18209762 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical